B. D. Cohen

发表

Identification and characterization of the neurofibromatosis type 1 protein product.

D. Lowy, J. Declue, B. D. Cohen, 1991, Proceedings of the National Academy of Sciences of the United States of America.

The Relationship between Human Epidermal Growth-like Factor Receptor Expression and Cellular Transformation in NIH3T3 Cells*

H. P. Fell, P. Kiener, B. D. Cohen, 1996, The Journal of Biological Chemistry.

Transformation-specific interaction of the bovine papillomavirus E5 oncoprotein with the platelet-derived growth factor receptor transmembrane domain and the epidermal growth factor receptor cytoplasmic domain

D. Lowy, J. Schiller, W. Vass, 1993, Journal of virology.

Antiangiogenic and antitumor activity of a selective PDGFR tyrosine kinase inhibitor, CP-673,451.

Jing Lin, B. D. Cohen, J. Lyssikatos, 2005, Cancer research.

HER4 Expression Correlates with Cytotoxicity Directed by a Heregulin-Toxin Fusion Protein (*)

H. P. Fell, B. D. Cohen, G. Plowman, 1995, The Journal of Biological Chemistry.

PF-03814735, an Orally Bioavailable Small Molecule Aurora Kinase Inhibitor for Cancer Therapy

L. Pustilnik, J. Christensen, B. D. Cohen, 2010, Molecular Cancer Therapeutics.

Role of epidermal growth factor receptor family members in growth and differentiation of breast carcinoma.

H. P. Fell, B. D. Cohen, S. Bacus, 1998, Biochemical Society symposium.

Discovery and synthesis of novel 4-aminopyrrolopyrimidine Tie-2 kinase inhibitors for the treatment of solid tumors.

Tracey Clark, Matthew D. Wessel, R. D. Connell, 2013, Bioorganic & medicinal chemistry letters.

The conserved C-terminal domain of the bovine papillomavirus E5 oncoprotein can associate with an alpha-adaptin-like molecule: a possible link between growth factor receptors and viral transformation

D. Lowy, J. Schiller, B. D. Cohen, 1993, Molecular and cellular biology.

HER4-mediated Biological and Biochemical Properties in NIH 3T3 Cells

H. P. Fell, B. D. Cohen, L. Foy, 1996, The Journal of Biological Chemistry.

Combination Therapy Enhances the Inhibition of Tumor Growth with the Fully Human Anti–Type 1 Insulin-Like Growth Factor Receptor Monoclonal Antibody CP-751,871

Mark W Tengowski, Faye Wang, P. Miller, 2005, Clinical Cancer Research.

Biochemical and pharmacological characterization of human c-Met neutralizing monoclonal antibody CE-355621

G. Karam, J. Lapointe, J. Xu, 2012, mAbs.

Betacellulin-Pseudomonas toxin fusion proteins bind but are not cytotoxic to cells expressing HER4; correlation of EGFR for cytotoxic activity

H. P. Fell, B. D. Cohen, S. Bacus, 1998, Oncogene.

Purification and characterization of phosphoinositide 3-kinase from rat liver.

L. Cantley, B. Schaffhausen, B. D. Cohen, 1990, The Journal of biological chemistry.